The Root Causes of Pharmacodynamic Assay Failure

Robust pharmacodynamic assay results are valuable for informing go/no‐go decisions about continued development of new anti-cancer agents and for identifying combinations of targeted agents, but often pharmacodynamic results are too incomplete or variable to fulfill this role. Our experience suggests that variable reagent and specimen quality are two major contributors to this problem. Minimizing all potential sources of variability in procedures for specimen collection, processing and assay measurements is essential for meaningful comparison of pharmacodynamic biomarkers across sample time points.
Source: Seminars in Oncology - Category: Cancer & Oncology Authors: Source Type: research